These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1517775)

  • 1. An approach to computer-aided inhibitor design: application to cathepsin L.
    Sudarsanam S; Virca GD; March CJ; Srinivasan S
    J Comput Aided Mol Des; 1992 Jun; 6(3):223-33. PubMed ID: 1517775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex.
    Tsuge H; Nishimura T; Tada Y; Asao T; Turk D; Turk V; Katunuma N
    Biochem Biophys Res Commun; 1999 Dec; 266(2):411-6. PubMed ID: 10600517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
    Estrada S; Pavlova A; Björk I
    Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype.
    Myers MC; Shah PP; Beavers MP; Napper AD; Diamond SL; Smith AB; Huryn DM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3646-51. PubMed ID: 18499453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
    Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
    J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on specificities of rat cathepsin L and papain: amino acid differences at substrate-binding sites are involved in their specificities.
    Koga H; Yamada H; Nishimura Y; Kato K; Imoto T
    J Biochem; 1990 Dec; 108(6):976-82. PubMed ID: 2089043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases.
    Jenko S; Dolenc I; Guncar G; Dobersek A; Podobnik M; Turk D
    J Mol Biol; 2003 Feb; 326(3):875-85. PubMed ID: 12581647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
    Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA
    Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papain.
    Auerswald EA; Nägler DK; Assfalg-Machleidt I; Stubbs MT; Machleidt W; Fritz H
    FEBS Lett; 1995 Mar; 361(2-3):179-84. PubMed ID: 7698319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino acid sequences, structure comparisons and inhibition kinetics of sheep cathepsin L and sheep stefin B.
    Ritonja A; Coetzer TH; Pike RN; Dennison C
    Comp Biochem Physiol B Biochem Mol Biol; 1996 Jun; 114(2):193-8. PubMed ID: 8759291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites.
    LaLonde JM; Zhao B; Smith WW; Janson CA; DesJarlais RL; Tomaszek TA; Carr TJ; Thompson SK; Oh HJ; Yamashita DS; Veber DF; Abdel-Meguid SS
    J Med Chem; 1998 Nov; 41(23):4567-76. PubMed ID: 9804696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.
    Portaro FC; Santos AB; Cezari MH; Juliano MA; Juliano L; Carmona E
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):123-9. PubMed ID: 10727410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L.
    Shah PP; Myers MC; Beavers MP; Purvis JE; Jing H; Grieser HJ; Sharlow ER; Napper AD; Huryn DM; Cooperman BS; Smith AB; Diamond SL
    Mol Pharmacol; 2008 Jul; 74(1):34-41. PubMed ID: 18403718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania major: molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors.
    Selzer PM; Chen X; Chan VJ; Cheng M; Kenyon GL; Kuntz ID; Sakanari JA; Cohen FE; McKerrow JH
    Exp Parasitol; 1997 Nov; 87(3):212-21. PubMed ID: 9371086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
    Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
    Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K.
    Marquis RW; Ru Y; Yamashita DS; Oh HJ; Yen J; Thompson SK; Carr TJ; Levy MA; Tomaszek TA; Ijames CF; Smith WW; Zhao B; Janson CA; Abdel-Meguid SS; D'Alessio KJ; McQueney MS; Veber DF
    Bioorg Med Chem; 1999 Apr; 7(4):581-8. PubMed ID: 10353637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary structure of bovine cathepsin S. Comparison to cathepsins L, H, B and papain.
    Wiederanders B; Broemme D; Kirschke H; Kalkkinen N; Rinne A; Paquette T; Toothman P
    FEBS Lett; 1991 Jul; 286(1-2):189-92. PubMed ID: 1864368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition.
    Hwang SR; Stoka V; Turk V; Hook VY
    Biochemistry; 2005 May; 44(21):7757-67. PubMed ID: 15909990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new function of kininogens as thiol-proteinase inhibitors: inhibition of papain and cathepsins B, H and L by bovine, rat and human plasma kininogens.
    Sueyoshi T; Enjyoji K; Shimada T; Kato H; Iwanaga S; Bando Y; Kominami E; Katunuma N
    FEBS Lett; 1985 Mar; 182(1):193-5. PubMed ID: 3972123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.